Alloy Ventures is an early-stage venture capital firm with over $1 billion under management that invests in the entrepreneurs creating the next generation of ground-breaking Information Technology, Life Sciences, and Cleantech companies. For the last 30 years, Alloy has leveraged the operational experience, extensive networks and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation. Some of our successful investments include Amgen, AMCC, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity – and our current portfolio includes companies like Barrx, Molecular Imprints, Optimedica, Pacific Biosciences, and Vivotech which are poised to become the next global leaders.